E.B. Sigg

475 citations
17 papers · 368 indexed · h-index 11

E.B. Sigg

17 papers receiving 292 citations

Peers

E.B. Sigg
Comparison fields: 5 of 69
  • Cellular and Molecular Neuroscience 153
  • Pharmacology 65
  • Urology 24
  • Physiology 78
  • Pharmacology 26
Replace Kirô Shimamoto with:
Kirô Shimamoto Japan
Svetislav K. Vanov United States
H Schmitt France
A Giudice Italy
D.F. Weetman United Kingdom
Donald H. Waters United States
F Huidobro Chile
B Delbarre France
Allison Reid Canada
Rudolf Weitzell Germany
E.B. Sigg relative to Kirô Shimamoto Japan Kirô Shimamoto's profile →
Citations per field
00.5×3.4×
Kirô Shimamoto · 1×
Citations per year

Countries citing papers authored by E.B. Sigg

Since Specialization
Citations

This map shows the geographic impact of E.B. Sigg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.B. Sigg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.B. Sigg more than expected).

Fields of papers citing papers by E.B. Sigg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.B. Sigg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.B. Sigg. The network helps show where E.B. Sigg may publish in the future.

Co-authorship network

The 17 scholars most cited alongside E.B. Sigg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with E.B. Sigg Line = papers co-authored together E.B. Sigg links everyone, so they are left out of the graph.

All Works

17 of 17 papers shown
#Work
1 19741
2 197215
3
The Pharmacology of Psychotherapeutic Drugs
196917
4 196914
5 196711
6 196622
7 19652
8 196431
9 196390
10 19636
11 19637
12 19632
13 19632
14 195861
15 195719
16 195719
17 195749

About E.B. Sigg

E.B. Sigg is a scholar working on Small Animals, Pharmacology, Cellular and Molecular Neuroscience, Pharmacology and Organic Chemistry, having authored 17 papers that have together received 368 indexed citations. Recurring topics across this work include Pain Mechanisms and Treatments (4 papers), Receptor Mechanisms and Signaling (3 papers), Synthesis and pharmacology of benzodiazepine derivatives (2 papers), Neuroscience and Neuropharmacology Research (2 papers), Pharmacological Receptor Mechanisms and Effects (2 papers), Veterinary Pharmacology and Anesthesia (2 papers), Neuroscience and Neural Engineering (2 papers) and Treatment of Major Depression (2 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (153 citations), Pharmacology (65 citations), Urology (24 citations), Physiology (78 citations) and Pharmacology (26 citations). E.B. Sigg has collaborated with scholars based in United States and Switzerland. Frequent co-authors include Jürg Schneider, Laszlo Gyermek, L. J. Soffer, Oleh Hornykiewicz, A. J. Plummer, Robert A. Maxwell, F Brücke, H.E. Spiegel, Glay Chinea and Walter Schlosser. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Pharmacology, Life Sciences, American Journal of Physiology-Legacy Content and Neuropharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026